These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3542653)

  • 21. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP; Neal L; Frankamp LM
    Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
    Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitus.
    Kennedy FP; Gerich JE
    Clin Pharmacol Ther; 1987 Oct; 42(4):455-8. PubMed ID: 3311550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial exercise in type I diabetic patients on multiple daily insulin injection regimen.
    Trovati M; Anfossi G; Vitali S; Mularoni E; Massucco P; De Facis R; Carta Q; Lucchina PG; Emanuelli G
    Diabetes Care; 1988 Feb; 11(2):107-10. PubMed ID: 3289860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of plasma insulin profiles after subcutaneous administration of insulin by jet spray and conventional needle injection in patients with insulin-dependent diabetes mellitus.
    Pehling GB; Gerich JE
    Mayo Clin Proc; 1984 Nov; 59(11):751-4. PubMed ID: 6387316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-mediated insulin resistance treated by cessation of insulin administration.
    Hara K; Tobe K; Uchigata Y; Nakazono M; Yasuda K; Terauchi Y; Iwamoto Y; Akanuma Y; Kimura S; Kadowaki T
    Intern Med; 2000 Feb; 39(2):143-5. PubMed ID: 10732832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
    Rassam AG; Zeise TM; Burge MR; Schade DS
    Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian variation of basal and postprandial insulin sensitivity in healthy individuals and patients with type-1 diabetes.
    Tatò F; Tatò S; Beyer J; Schrezenmeir J
    Diabetes Res; 1991 May; 17(1):13-24. PubMed ID: 1816976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
    Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.
    Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N
    Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels.
    Spectre G; Stålesen R; Östenson CG; Hjemdahl P
    Thromb Res; 2016 May; 141():93-7. PubMed ID: 26994470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia.
    Beisswenger PJ; Howell SK; O'Dell RM; Wood ME; Touchette AD; Szwergold BS
    Diabetes Care; 2001 Apr; 24(4):726-32. PubMed ID: 11315838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control.
    Famulla S; Hövelmann U; Fischer A; Coester HV; Hermanski L; Kaltheuner M; Kaltheuner L; Heinemann L; Heise T; Hirsch L
    Diabetes Care; 2016 Sep; 39(9):1486-92. PubMed ID: 27411698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.